adverse outcomes. An integrative and collaborative interprofessional team can greatly improve outcomes for patients with this disease. [Level V] Current evidence regarding when to initiate treatment is still sketchy. Trials such as the TIMING study are likely to add valuable information to the existing knowledge base. ## Review Questions - [Access free multiple choice questions on this topic.](https://www.statpearls.com/account/trialuserreg/?articleid=18913&utm_source=pubmed&utm_campaign=reviews&utm_content=18913) - [Click here for a simplified version.](https://mdsearchlight.com/stroke/cardioembolic-stroke-stroke/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=18913) - [Comment on this article.](https://www.statpearls.com/articlelibrary/commentarticle/18913/?utm_source=pubmed&utm_campaign=comments&utm_content=18913) ## References 1. Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C., Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010). GBD Stroke Experts Group. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013 Nov;1(5):e259-81. \[[PMC free article: PMC4181351](/pmc/articles/PMC4181351/)\] \[[PubMed: 25104492](https://pubmed.ncbi.nlm.nih.gov/25104492)\] 2. Díaz Guzmán J. [Cardioembolic stroke: epidemiology]. Neurologia. 2012 Mar;27 Suppl 1:4-9. \[[PubMed: 22682204](https://pubmed.ncbi.nlm.nih.gov/22682204)\] 3. Ferro JM. Cardioembolic stroke: an update. Lancet Neurol. 2003 Mar;2(3):177-88. \[[PubMed: 12849239](https://pubmed.ncbi.nlm.nih.gov/12849239)\] 4. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010 Aug;6(3):150-61. \[[PMC free article: PMC2994107](/pmc/articles/PMC2994107/)\] \[[PubMed: 21804774](https://pubmed.ncbi.nlm.nih.gov/21804774)\] 5. Yuan K, Kasner SE. Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention. Stroke Vasc Neurol. 2018 Jun;3(2):84-91. \[[PMC free article: PMC6047340](/pmc/articles/PMC6047340/)\] \[[PubMed: 30022802](https://pubmed.ncbi.nlm.nih.gov/30022802)\] 6. Di Tullio MR, Homma S. Mechanisms of cardioembolic stroke. Curr Cardiol Rep. 2002 Mar;4(2):141-8. \[[PubMed: 11827638](https://pubmed.ncbi.nlm.nih.gov/11827638)\] 7. Weir NU. An update on cardioembolic stroke. Postgrad Med J. 2008 Mar;84(989):133-42; quiz 139-40. \[[PubMed: 18372484](https://pubmed.ncbi.nlm.nih.gov/18372484)\] 8. Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, Price TR, Hier DB. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke. 1992 Apr;23(4):486-91. \[[PubMed: 1561677](https://pubmed.ncbi.nlm.nih.gov/1561677)\] 9. Spence JD. Cardioembolic stroke: everything has changed. Stroke Vasc Neurol. 2018 Jun;3(2):76-83. \[[PMC free article: PMC6047338](/pmc/articles/PMC6047338/)\] \[[PubMed: 30022801](https://pubmed.ncbi.nlm.nih.gov/30022801)\] 10. Mir H, Siemieniuk RAC, Ge L, Foroutan F, Fralick M, Syed T, Lopes LC, Kuijpers T, Mas JL, Vandvik PO, Agoritsas T, Guyatt GH. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence. BMJ Open. 2018 Jul 25;8(7):e023761. \[[PMC free article: PMC6067350](/pmc/articles/PMC6067350/)\] \[[PubMed: 30049703](https://pubmed.ncbi.nlm.nih.gov/30049703)\] **Disclosure:** Ashwin Pillai declares no relevant financial relationships with